THE EFFECT OF SIMVASTATIN, ASPIRIN, THEIR COMBINATION AND BUNGUR ETHANOLIC EXTRACT (Lagerstroemia speciosa (L.) Pers.) IN INITIATION STEP OF ATHEROMA PLAQUE
Atherosclerosis is one of the risk factors of cardiovascular disease. Atherosclerosis is a chronic inflammatory disease caused by high level of cholesterol especially Low Density Lipoprotein (LDL) and accumulation of neutrophil and macrophage in the artery wall. Purpose of this research was to id...
Saved in:
Main Author: | |
---|---|
Format: | Theses |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/45961 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Summary: | Atherosclerosis is one of the risk factors of cardiovascular disease. Atherosclerosis is a chronic
inflammatory disease caused by high level of cholesterol especially Low Density Lipoprotein (LDL)
and accumulation of neutrophil and macrophage in the artery wall. Purpose of this research was to
identify the effect of simvastatin, aspirin, their combination and bungur ethanolic extract to
thickness of aorta wall which is initiation step of atherosclerosis plaque through lipid profile
including total cholesterol, HDL and LDL and inflammation profile including myeloperoxidase
(MPO) and interleukin-18 (IL-18). Atherosclerosis’s model induced by cholesterol-fed and CCT
(cholesterol, cholic acid, and propiltiouracil) oral administration. Rats induced cholesterol divided
into control group, simvastatin 25 mg/kg, aspirin 20 mg/kg bb, combination simvastatin 25 mg/kg
and aspirin 20 mg/kg and bungur ethanolic extract 200 mg/kg. Therapy was given 1 week to
atherosclerosis’s model and still induced with cholesterol. Then, therapy was still given 2 weeks but
induction of high cholesterol was stopped due to the massive loss of body weight. Cholesterol total,
triglyseride, HDL, LDL, myeloperoxidase, and interleukin-18 measured before induction, end of
induction, and end of therapy. In the end of therapy, aorta’s rats was isolated to identify the
thickness of aorta wall. Cholesterol level of simvastatin, aspirin, combination and extract (99,13 ±
24,16 mg/dL, 96,89 ± 22,34 mg/dL , 98,87 ± 16,92 mg/dL and 101,18 ± 12,52 mg/dL, respectively)
were significantly lower compared to control group (p<0,05). Triglyseride level of simvastatin,
aspirin, and extract (115,78 ± 34,05 mg/dL, 86,02 ± 24,45 mg/dL, and 75,21 ± 30,40 mg/dL,
respectively) were significantly lower compared to control group (p<0,05). HDL level of all groups
did not show significantly different compared to control group (p>0,05). LDL level of combination
group (41,25 ± 20,93 mg/dL) was significantly lower compared to control group (p<0,05).
Myeloperoxidase level of simvastatin, aspirin, combination and extract (0,223 ± 0,100 ng/mL,
0,073 ± 0,052 ng/mL, 0,120 ± 0,027 ng/mL and 0,047 ± 0,017 ng/mL, respectively) were
significantly lower compared to control group (p<0,05). Interleukin-18 level of simvastatin, aspirin,
combination and extract (0,123 ± 0,011 ng/mL, 0,095 ± 0,005 ng/mL , 0,102 ± 0,009 ng/mL and
0,120 ± 0,011 ng/mL, respectively) were significantly lower compared to control group (p<0,05).
Thickness of aorta wall of simvastatin, aspirin, combination and extract (158,60 ± 38,34 µm, 130,00
± 20,55 µm, 156,00 ± 18,17 µm and 186,0 ± 23,02 µm, respectively) were significantly lower
compared to control group (p<0,05). Simvastatin 25 mg/kg and bungur ethanolic extract 200 mg/kg
group inhibit the thickness of aorta wall accompanied by decreasing cholesterol level, MPO level,
and IL-18 level. Aspirin 20 mg/kg group has a better effect to inhibit the thickness of aorta wall
accompanied by decreasing cholesterol level, MPO and IL-18. Simvastatin 25 mg/kg and aspirin 20
mg/kg combination group has effect to inhibit the thickness of aorta wall accompanied by
decreasing cholesterol level, MPO, and IL-18.
|
---|